Buyer
NHS England
Sector
Pharmaceutical products
Awarded To
CSL Behring UK Ltd, Mylan, Abbvie Ltd, Lupin Healthcare (UK) Limited, Celix Pharma Ltd., Morningside Pharmaeuticals, Day Lewis Medical Ltd, Zentiva Pharma UK Ltd, Aspire Pharma Limited, Takeda UK Ltd, Pfizer Ltd, Merz, Mercury Pharmaceuticals Limited, INFECTOPHARM LTD, Synchrony, medac Pharma LLP, Recordati Rare Diseases UK Ltd, Teva UK Limited, Sandoz Ltd, Sun Pharma UK Ltd, Neon Healthcare Ltd, Accord-UK Ltd, Colonis Pharma Ltd, Provepharm UK Ltd, Organon Pharmaceuticals UK Ltd, Neuraxpharm UK Ltd, Kyowa Kirin International UK New Co Ltd, BioCryst Ireland Limited, Bayer Plc, Essential Pharma, ROVI Biotech Ltd, Wockhardt UK Limited, Glenmark Pharmaceuticals Europe Limited, Selective Supplies Ltd., CST Pharma Limited, Otsuka Pharmaceuticals UK Limited, Chiesi Limited, Baxter Healthcare Ltd, Pharming Group, Janssen-Cilag Ltd, Ipsen, Pharmasure, Dexcel Pharma Ltd, Besins Healthcare UK LTD, Astellas Pharma Ltd, Merck Serono Limited, Orifarm UK, SERB SA, Drugsrus Ltd, Grunenthal, Galen Limited, Aventis Pharma ltd t/a Sanofi, Esteve Pharmaceuticals Ltd, Novo Nordisk, Xiromed, Strandhaven Ltd t/a Somex Pharma, Nordic Pharma, Ridge Pharma, G.L. Pharma UK Limited, Theramex HQ UK, Ferring Pharmaceuticals Ltd, Aspen Pharmacare UK Limited, Eisai Ltd, Novartis Pharmaceuticals UK Ltd, Alissa Healthcare Research Limited, Tillomed Laboratories ltd, Gedeon Richter UK Ltd, Napp Pharmaceuticals Ltd, Rayner Surgical Group Ltd, Norgine Pharmaceuticals Limited, Thornton and Ross Ltd, FLYNN PHARMA LTD
Status
complete
Published
22 Apr 2025, 16:48